IP Library Granted Patent US 10,731,141
Granted Patent B2
US 10,731,141 · App. 16/567,598 · Granted Aug 4, 2020

Engineered polymerases for improved sequencing

Inventor: Pinar Iyidogan (San Diego, CA)
Assignee: OMNIOME, INC.
C12N9/1252C12N9/1276C12P19/34C12Q1/6874C12Y207/07007C12Y207/07049
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,731,141
App. No.
16/567,598
Granted
Aug 4, 2020
Kind
B2
Abstract

Provided are nucleic acids encoding engineered polymerases comprising at least one modification in a motif A and/or at least one modification in a motif B of the polymerase and engineered polymerases encoded by the nucleic acids. Also provided are engineered DNA polymerases comprising a variant of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:3, the variant being at least 80% identical to SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3 and comprising an amino acid substitution at one or more positions selected from the group consisting of L408, Y409, P410, R484, A/L485, and I486. Methods, vectors, kits, and compositions comprising the nucleic acids and compositions, methods and kits comprising the engineered polymerases are also provided.

Claims (22)

1. An engineered DNA polymerase comprising a variant of SEQ ID NO:1, the variant being at least 95% identical to SEQ ID NO:1, the variant comprising amino acid substitutions L408F, Y409F and P410T wherein the engineered DNA polymerase has increased accuracy in pairing nucleotides to template bases as compared to a control polymerase having amino acid sequence of SEQ ID NO:1.

2. An engineered DNA polymerase comprising a variant of SEQ ID NO:1, the variant being at least 95% identical to SEQ ID NO:1, the variant comprising amino acid amino acid substitutions L408F, Y409H, and P410V, wherein the engineered DNA polymerase has increased accuracy in pairing nucleotides to template bases as compared to a control polymerase having amino acid sequence of SEQ ID NO:1.

3. The engineered polymerase of claim 1 , wherein the variant further comprises modifications at amino acid positions R484 and A/L485, R484 and I486, A/L485 and I486, or R484, A/L485 and I486.

4. The engineered polymerase of claim 1 , wherein the variant further comprises a modification at amino acid position D141 and/or E143.

5. The engineered polymerase of claim 4 , wherein the modifications are D141A and E143A.

6. The engineered polymerase of claim 1 , wherein the engineered DNA polymerase is a B-type family polymerase.

7. The engineered polymerase of claim 1 , wherein the engineered DNA polymerase has increased stability as compared to a control polymerase.

8. The engineered polymerase of claim 1 , wherein the engineered DNA polymerase has improved polymerization kinetic rates as compared to a control polymerase.

9. The engineered polymerase of claim 1 , wherein the engineered DNA polymerase has decreased polymerization error rates as compared to a control polymerase.

10. The engineered polymerase of claim 1 , wherein the engineered DNA polymerase has an average error rate of less than 0.75 at 100 cycles of a sequencing by binding process.

11. The engineered polymerase of claim 1 , wherein the engineered DNA polymerase has an average error rate of less than 8 at 150 cycles of a sequencing by binding process.

12. The engineered polymerase of claim 1 , wherein the engineered DNA polymerase has an average error rate of between 1 and 5 at 150 cycles of a sequencing by binding process.

13. The engineered polymerase of claim 2 , wherein the variant further comprises modifications at amino acid positions R484 and A/L485, R484 and I486, A/L485 and I486, or R484, A/L485 and I486.

14. The engineered polymerase of claim 2 , wherein the variant further comprises a modification at amino acid position D141 and/or E143.

15. The engineered polymerase of claim 2 , wherein the modifications are D141A and E143A.

16. The engineered polymerase of claim 2 , wherein the engineered DNA polymerase is a B-type family polymerase.

17. The engineered polymerase of claim 2 , wherein the engineered DNA polymerase has increased stability as compared to a control polymerase having amino acid sequence of SEQ ID NO:1.

18. The engineered polymerase of claim 2 , wherein the engineered DNA polymerase has improved polymerization kinetic rates as compared to a control polymerase having amino acid sequence of SEQ ID NO:1.

19. The engineered polymerase of claim 2 , wherein the engineered DNA polymerase has decreased polymerization error rates as compared to a control polymerase having amino acid sequence of SEQ ID NO:1.

20. The engineered polymerase of claim 2 , wherein the engineered DNA polymerase has an average error rate of less than 0.75 at 100 cycles of a sequencing by binding process.

21. The engineered polymerase of claim 2 , wherein the engineered DNA polymerase has an average error rate of less than 8 at 150 cycles of a sequencing by binding process.

22. The engineered polymerase of claim 2 , wherein the engineered DNA polymerase has an average error rate of between 1 and 5 at 150 cycles of a sequencing by binding process.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: OMNIOME, LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 059278/0153 →
MERGER Recorded Feb 2, 2022
From: OMNIOME, INC.
To: OMNIOME, LLC
Reel/Frame 058952/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2019
From: IYIDOGAN, PINAR
To: OMNIOME, INC.
Reel/Frame 050655/0178 →
Continuity (2)
Provisional Application 62732510 · Sep 17, 2018
Related Publication 20200087638A1 · Mar 19, 2020
Cited By (13)
US 12,241,891 US 12,359,193 US 12,365,892 US 12,371,743 US 12,398,176 US 12,421,545 US 12,469,162 US 12,480,115 US 12,505,571 US 12,509,669 US 12,516,374 US 12,540,350 US 12,606,819